Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Efamol
Surrey (historical, HQ/operations), United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
Efamol’s products (evening primrose oil, Efalex Brain Formula, Active Memory) have been the subject of over 300 clinical studies evaluating effects on cognitive performance, memory in older adults, brain development in children, skin health, and overall wellness, most showing supportive if sometimes modest clinical results[2][5][6][8].
- Therapeutic areas
- DermatologyNeurologyOtherRheumatology
- Modalities
- Nutritional supplementOil extractSmall molecule (fatty acids including omega-3 and omega-6/GLA)
- Industry
- Food & Nutrition
02
Partnerships
University of Roehampton (academic partnership)Academic collaborations with Professor Simon Dyall and Dr. Alex Richardson
Beyond the preview
Go deeper on Efamol.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Efamol.